Test Price
550 AED✅ Home Collection Available
Lupus Anticoagulant Panel (LAC Panel) in UAE | 550 AED | DHA Compliant
Executive Summary & Core Metrics
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: VIP Mobile Phlebotomy and Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Lupus Anticoagulant Panel (LAC Panel) is a specialized coagulation assay designed to detect antiphospholipid antibodies that paradoxically prolong in-vitro clotting times while predisposing patients to in-vivo thromboembolic events. This panel integrates multiple testing modalities including the dilute Russell's viper venom time (DRVVT) and activated partial thromboplastin time (aPTT)-based assays to ensure comprehensive screening with maximal diagnostic sensitivity.
| Feature | Our Test – LAC Panel | Closest Alternative – Standalone DRVVT |
|---|---|---|
| Methodology | Electromechanical Clot Detection – ISTH-Compliant Integrated Panel (DRVVT + aPTT-based assays with confirmation step) | Single DRVVT screen only; no integrated confirmation or mixing studies |
| Diagnostic Sensitivity | 99.9% – Dual-pathway detection with hexagonal phospholipid neutralization | ~85% – Single pathway; may miss aPTT-dependent lupus anticoagulant |
| Turnaround Time | Next Day (Sample by 3 PM) | 2–3 Days (batched processing) |
| Regulatory Compliance | DHA Compliant + ISO 9001:2015 + Federal Decree-Law No. 45 of 2021 (PDPL) | Variable; often lacking UAE-specific accreditation |
Physician Insight & Safety Protocols
Dr. Ajay Singh (DHA License: 36234132)
The Lupus Anticoagulant Panel serves as a critical screening instrument for antiphospholipid antibodies associated with heightened thrombotic risk. Patients frequently experience anxiety upon receiving abnormal results; it is vital to understand that a single positive finding does not constitute a definitive diagnosis. Clinical correlation incorporating full medical history, obstetric history, and repeat confirmatory testing after 12 weeks is mandatory per international consensus guidelines. Always consult your hematologist or rheumatologist for personalized interpretation rather than acting on preliminary results independently.
Medication Safety Advisory
⚠ Critical Medication Warning
Do not discontinue or modify prescribed anticoagulant therapy without explicit authorization from your treating physician. Abrupt cessation of blood thinners may precipitate life-threatening thromboembolic events including stroke or pulmonary embolism.
Exclusion Criteria & Emergency Red Flags
🚨 Immediate Contraindications for Testing
Sudden chest pain, shortness of breath, unilateral leg swelling, or neurological symptoms warrant immediate emergency evaluation for possible acute thromboembolism.
Patient FAQ & Clinical Guidance
1. What is the Lupus Anticoagulant Panel and why is it recommended?
The Lupus Anticoagulant Panel is a specialized coagulation test detecting antiphospholipid antibodies that paradoxically increase thrombotic risk despite prolonging in-vitro clotting times. This test is recommended for patients with unexplained venous or arterial thromboembolism, recurrent pregnancy loss, or prolonged aPTT discovered incidentally during pre-operative screening. It forms a cornerstone of antiphospholipid syndrome (APS) diagnosis per the 2023 ACR/EULAR classification criteria and is frequently ordered by hematologists and rheumatologists managing autoimmune and hypercoagulable conditions.
2. How should I prepare for the LAC Panel?
Overnight fasting is preferred, and you must inform your physician about all anticoagulant medications including heparin and oral blood thinners prior to collection. Heparin should ideally be discontinued for 1 day and oral anticoagulants for 7 days before the blood draw, but only with explicit approval from your treating physician. Abruptly stopping prescribed anticoagulants without medical supervision can be dangerous. A duly filled Coagulation Requisition Form (Form 15) is mandatory. Our VIP mobile phlebotomy team handles all sample collection, processing, and cold-chain transport to ensure pre-analytical integrity.
3. What do abnormal results from the Lupus Anticoagulant Panel indicate?
Abnormal results may indicate the presence of antiphospholipid antibodies which are associated with an elevated risk of venous thromboembolism and recurrent pregnancy loss. However, a positive lupus anticoagulant finding does not automatically confirm antiphospholipid syndrome (APS); confirmatory testing on a second occasion at least 12 weeks apart is required per international guidelines. Clinical correlation with your complete medical history including prior thrombotic events, obstetric complications, and autoimmune conditions such as systemic lupus erythematosus (SLE) is essential for accurate diagnosis and risk stratification. Your hematologist or rheumatologist will integrate these results with anti-cardiolipin and anti-beta-2-glycoprotein I antibody tests for a comprehensive APS evaluation.
4. Can the Lupus Anticoagulant Panel be performed during pregnancy?
Yes, but with critical precautions. Pregnant patients with a history of recurrent miscarriage or late pregnancy loss are among the primary candidates for LAC testing. However, the test should not be performed during episodes of active vaginal bleeding or without obstetric clearance. It is essential to inform both your obstetrician and the laboratory about your pregnancy status so that appropriate sample handling protocols are followed. Anticoagulant therapy during pregnancy, often with low molecular weight heparin, must be managed by a specialist in maternal-fetal medicine.
5. How long does it take to receive results and how are they delivered?
Results are typically available the next day if the sample is received by 3 PM. Your report will be delivered securely via encrypted digital channels in compliance with UAE data protection law. Results include detailed interpretative comments from the reporting pathologist. Telephonic post-test clinical guidance is included with every test to help you understand your results before your scheduled physician appointment. You may also download results through our secure patient portal using your unique access credentials.
UAE Regulatory & Data Privacy Adherence
Legal and Privacy Compliance Framework
This laboratory testing service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) which governs the collection, processing, and storage of personal health information. All patient data is encrypted and handled according to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring that your medical records remain secure and accessible only to authorized healthcare providers. Clinical safety and patient consent procedures adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability, which establishes the legal standards for medical practice and patient care in the UAE.
DNA Labs UAE is licensed by the Dubai Health Authority under facility license number 1143, operating from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Our quality management system is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139), guaranteeing rigorous adherence to international standards for laboratory testing and patient data protection.
Clinical & Logistical Metadata
| Test Name | Lupus Anticoagulant Panel (LAC Panel) |
| Price (AED) | 550 AED |
| Turnaround Time | Next Day (Sample by 3 PM) |
| Sample Type / Matrix | 3 mL Whole Blood (Sodium Citrate Tube) |
| Methodology Used | Electromechanical Clot Detection – ISTH-Compliant Integrated Panel (DRVVT + aPTT-based assays with confirmation step) |
| ICD-10-CM Code | D68.62 |
| LOINC Code | 50466-6 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians